Novartis: Stomach Neoplasms trials
The registry lists 13 Stomach Neoplasms studies with Novartis as lead sponsor. 1 are open to participants now and 2 have results posted.
Phase 1 8Phase 2 5Phase 3 1(a study in two phases counts in both)
Studies
Open to participants first, then studies with results posted, then the rest; newest registration first within each.
- A Study of [68Ga]Ga-DWJ155 in Adult Patients With Solid TumorsRecruitingNCT07801508Phase 1
- Everolimus in Combination With Imatinib in Patients With Glivec Refractory/Resistant Gastrointestinal Stromal TumorsCompletedNCT01275222Phase 1/2Results posted
- Safety and Efficacy of RAD001 (Everolimus) Monotherapy Plus Best Supportive Care in Patients With Advanced Gastric Cancer (AGC)CompletedNCT00879333Phase 3Results posted
- A Phase I Study of [177Lu]Lu-FF58 in Patients With Advanced Solid Tumors.TerminatedNCT05977322Phase 1
- PI3K Inhibitor BYL719 in Combination With the HSP90 Inhibitor AUY922 in Patients With Advanced or Metastatic Gastric CancerCompletedNCT01613950Phase 1
- Phase I Study LJM716 Combined With Trastuzumab in Patients With HER2 Overexpressing Metastatic Breast or Gastric CancerCompletedNCT01602406Phase 1
- A Phase I Study of LJM716 in Squamous Cell Carcinoma of Head and Neck, or HER2+ Breast Cancer or Gastric CancerCompletedNCT01598077Phase 1
- Phase Ib, Dose Escalation Study of Oral LDE225 in Combination With BKM120 in Patients With Advanced Solid TumorsCompletedNCT01576666Phase 1
- A Phase II Study to Evaluate Efficacy and Safety of Dovitinib (TKI258) in Advanced Scirrhous Gastric Carcinoma PatientsCompletedNCT01576380Phase 2
- Phase II of AUY922 in Second-line Gastric Cancer in Combination With Trastuzumab in HER2 Positive PatientsTerminatedNCT01402401Phase 2
- Phase II Trial of AUY922 vs. Comparators in Advanced Gastric CancerCompletedNCT01084330Phase 2
- Safety and Immunogenicity of Chiron's Investigational H. Pylori Vaccine in Healthy AdultsCompletedNCT00613665Phase 1
- Efficacy and Safety of Everolimus (RAD001) in Patients With Advanced Gastric CancerCompletedNCT00519324Phase 2